@article { ISI:000281964300014,
	title = {OGA inhibition by GlcNAc-selenazoline},
	journal = {BIOORGANIC \& MEDICINAL CHEMISTRY},
	volume = {18},
	number = {19},
	year = {2010},
	month = {OCT 1},
	pages = {7058-7064},
	abstract = {The title compound, which differs from the powerful O-GlcNAcase (OGA) inhibitor GlcNAc-thiazoline only at the chalcogen atom (Se for S), is a much weaker inhibitor in a direct OGA assay. In human cells, however, the selenazoline shows comparable ability to induce hyper-O-GlcNAc-ylation, and the two show similar reduction of insulin-stimulated translocation of glucose transporter 4 in differentiated 3T3 adipocytes. (C) 2010 Elsevier Ltd. All rights reserved.},
	issn = {0968-0896},
	doi = {10.1016/j.bmc.2010.08.010},
	author = {Kim, Eun Ju and Love, Dona C. and Darout, Etzer and Abdo, Mohannad and Rempel, Brian and Withers, Stephen G. and Rablen, Paul R. and Hanover, John A. and Knapp, Spencer}
}
